U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07940777) titled 'A Study to Evaluate the Safety and Efficacy of Mavacamten in Adults With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy (SOLSTICE-HCM)' on Oct. 29.

Brief Summary: A study to evaluate the safety and efficacy of Mavacamten in adults with Symptomatic Non-obstructive Hypertrophic Cardiomyopathy (SOLSTICE-HCM)

Study Start Date: Dec. 29

Study Type: INTERVENTIONAL

Condition: Non-obstructive Hypertrophic Cardiomyopathy

Intervention: DRUG: Mavacamten

Specified dose on specified days

OTHER: Placebo

Specified dose on specified days

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Bristol-Myers Squibb

Published by HT Digital...